Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases

Br J Ophthalmol. 2007 Dec;91(12):1716-7. doi: 10.1136/bjo.2006.108639.

Authors

K C Madhusudhana¹, S R Hannan, C P R Williams, S V Goverdhan, C Rennie, A J Lotery, A J Luff, R S B Newsom

Affiliation

¹ Southampton Eye Unit, Tremona Road, Southampton S016 6YD, UK.

No abstract available

MeSH terms

Aged
Aged, 80 and over
Angiogenesis Inhibitors / administration & dosage*
Angiogenesis Inhibitors / therapeutic use
Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Choroidal Neovascularization / complications*
Choroidal Neovascularization / drug therapy*
Choroidal Neovascularization / physiopathology
Female
Follow-Up Studies
Humans
Injections
Macula Lutea
Macular Degeneration / complications*
Macular Degeneration / diagnosis
Male
Middle Aged
Retrospective Studies
Tomography, Optical Coherence
Visual Acuity
Vitreous Body

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab